IPOs and Catalysts/Events, Global Equity Research Ltd

Arun George

IPOs and Catalysts/Events

Uncompromised, Independent, Conflict-Free Research

Global Equity Research Ltd

Global Equity Research was started in 2017 by a group of experienced research professionals. It was founded on a passionate belief in the importance and the need for uncompromised, independent, conflict-free research. We aim to provide differentiated and actionable primary and bottom up fundamental research.

Event-Driven

<ul>
<li>
<a href="https://www.smartkarma.com/entities/singapore-medical-group-ltd" target="_blank" data-smartkarma-citation="entities:7441:1" rel="noopener">Singapore Medical (SMG SP)</a> received a voluntary conditional offer from management (chairman, CEO, exec director). The offer is cash (S$0.37) or scrip (1 new share in the offeror per share).</li>
<li>The key condition is a 90% minimum acceptance condition. Irrevocables, which will take the scrip option, represent 51.67% of outstanding shares.</li>
<li>The offer is light, but the offeror reserves the right to reduce the acceptance condition to a lower level (above 50%). Therefore, this offer will likely turn unconditional. </li>
</ul>



Singapore Medical (SMG SP) received a voluntary conditional offer from management (chairman, CEO, exec director). The offer is cash (S$0.37) or scrip (1 new share in the offeror per share).
The key condition is a 90% minimum acceptance condition. Irrevocables, which will take the scrip option, represent 51.67% of outstanding shares.
The offer is light, but the offeror reserves the right to reduce the acceptance condition to a lower level (above 50%). Therefore, this offer will likely turn unconditional. 


Singapore Medical’s Light VGO Offer from Top Management

Smartkarma Research Team, Smartkarma

Smartkarma Research

Smartkarma Research Team

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

Equity Bottom-Up

<p>For our next Corporate Webinar, we are glad to welcome the Chief Executive Officer of <a href="https://www.smartkarma.com/entities/singapore-o-g-ltd" target="_blank" data-smartkarma-citation="entities:26976:1" rel="noopener">Singapore O&amp;G Ltd. (SOG SP)</a>, Eric Choo. </p><p>Established in 2011 and listed on SGX in June 2015, SOG is a leading healthcare service provider dedicated towards delivering premier medical services to women's and children's health and wellness at affordable prices. The Group's clinics, under its four operating segments - O&amp;G, Paediatrics, Cancer-related, and Dermatology - are strategically located throughout Singapore to provide easy access to its patients.</p><p>In this Webinar, Eric will share a short company presentation, after which he will engage in a fireside chat with Smartkarma Insight Provider, <a href="https://www.smartkarma.com/profiles/xinyao-criss-wang" target="_blank" data-smartkarma-citation="accounts:14483" rel="noopener">Xinyao (Criss) Wang</a>. This will be followed by a live Q&amp;A session.</p><h3>The Corporate Webinar will be hosted on Tuesday, 17 August 2021, 17:00 SGT</h3><div class="content-highlight"><h2><a href="https://share.hsforms.com/1H9pFZOB-RF2J00kbvMmxcw2c5gj?zoom_webinar_id=88033984045" target="_blank" rel="noopener">Register for the Webinar here</a></h2></div><p>Corporate Webinars by <a href="https://www.smartkarma.com/home/corporate-solutions/" target="_blank" rel="noopener">Smartkarma Corporate Solutions</a> feature discussions with IROs and Executives, discussing their companies, the challenges they face, and the opportunities in their sectors and markets.</p>

For our next Corporate Webinar, we are glad to welcome the Chief Executive Officer of Singapore O&amp;G Ltd. (SOG SP), Eric Choo. Established in 2011 and listed on SGX in June 2015, SOG is a leading healthcare service provider dedicated towards delivering premier medical services to women's and children's health and wellness at affordable prices. The Group's clinics, under its four operating segments - O&amp;G, Paediatrics, Cancer-related, and Dermatology - are strategically located throughout Singapore to provide easy access to its patients.In this Webinar, Eric will share a short company presentation, after which he will engage in a fireside chat with Smartkarma Insight Provider, Xinyao (Criss) Wang. This will be followed by a live Q&amp;A session.The Corporate Webinar will be hosted on Tuesday, 17 August 2021, 17:00 SGTRegister for the Webinar hereCorporate Webinars by Smartkarma Corporate Solutions feature discussions with IROs and Executives, discussing their companies, the challenges they face, and the opportunities in their sectors and markets.

Smartkarma Corporate Webinar | Singapore O&G: Nurturing Women’s and Children’s Health in Singapore

APAC IPOs & Placements

Zhen Zhou, Toh

Qualitas Medical Group / Equity Bottom-Up

<p><a href="https://www.smartkarma.com/entities/26971" target="_blank" data-smartkarma-citation="entities:26971:1" rel="noopener">Qualitas Medical Group (QMGL SP)</a> is looking to raise approximately US$102m in its upcoming IPO. The company will be using the proceeds to make strategic investments and acquisitions, seek out organic growth and initiatives, and general corporate purposes.</p>
<p>In this insight, we will look at the company's business, examine the changes since it got privatized in 2011, compare it against other regional healthcare peers. We will also run the deal through our ECM framework.</p>

Qualitas Medical Group (QMGL SP) is looking to raise approximately US$102m in its upcoming IPO. The company will be using the proceeds to make strategic investments and acquisitions, seek out organic growth and initiatives, and general corporate purposes.
In this insight, we will look at the company's business, examine the changes since it got privatized in 2011, compare it against other regional healthcare peers. We will also run the deal through our ECM framework.

Qualitas Medical Group IPO Review - Valuation up 95% in One Month

Singapore

Established in 2011, Singapore O&G Ltd. (SOG) is a leading healthcare service provider dedicated towards delivering premier medical services to women's and children's health and wellness at affordable prices.

With a long and established track record in Singapore providing obstetrics and gynaecology (O&G) services such as pre-pregnancy counselling, delivery, pregnancy and post-delivery care, the Group has since further expanded its spectrum of healthcare services to include paediatrics, endocrinology, gynaecological cancer, cancer-related general surgery for breast, thyroid and colon (colorectal), as well as skin and aesthetics treatments.

The Group's clinics, under its four operating segments of O&G, Paediatrics, Cancer-related and Dermatology are strategically located throughout Singapore to provide easy access to its patients. 

SOG has been listed in the Catalist board of the Singapore Exchange Securities Trading Limited since 4 June 2015.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Singapore O&G Ltd. (SOG SP)

Singapore Medical’s Light VGO Offer from Top Management

The offer is light, but the offeror reserves the right to reduce the acceptance condition to a lower level (above 50%). At the last close, the...

Arun George

Smartkarma Corporate Webinar | Singapore O&G: Nurturing Women’s and Children’s Health in Singapore

On 17 August, 5pm SGT, join us for a discussion and presentation on Singapore O&G Ltd with CEO Eric Choo. Eric will have a fireside chat with Criss...

Smartkarma Research

Qualitas Medical Group IPO Review - Valuation up 95% in One Month

Qualitas Medical Group (QMGL SP) is looking to raise approximately US$102m in its upcoming IPO. The company will be using the proceeds to make...

Zhen Zhou, Toh

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)